SCHEMBL1462353

SCHEMBL1462353

OC(CN1CCN(c2cnccn2)CC1)c1ccc(Cl)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 5/20 0.55
KDM4E B2RXH2 3/20 0.51
HTT P42858 3/20 0.51
LMNA P02545 2/20 0.51
MAPT P10636 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
SORD Q00796 1/20 0.45
GAA P10253 1/20 0.45
POLB P06746 1/20 0.45
ADRB2 P07550 2/20 0.44
ADRB1 P08588 2/20 0.44
ADRB3 P13945 2/20 0.44
ADRA1D P25100 2/20 0.44
ADRA1A P35348 2/20 0.44
ADRA1B P35368 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
DRD2 P14416 2/20 0.43
DRD4 P21917 2/20 0.43
ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11969592 0.88 IGF1R (0.55) IGF1RKDM4ELMNASMN1; SMN2SORD
SCHEMBL11968814 0.88 IGF1R (0.55) IGF1RKDM4EHTTMAPTGAA
SCHEMBL1460259 0.87 IGF1R (0.60) IGF1RKDM4ELMNASMN1; SMN2GAA
SCHEMBL11968975 0.79 IGF1R (0.48) IGF1RKDM4ELMNAMAPTSMN1; SMN2
SCHEMBL9492429 0.76 SORD (0.51) KDM4ELMNAMAPTSMN1; SMN2SORD
SCHEMBL1461590 0.76 IGF1R (0.47) IGF1RKDM4ELMNAMAPTSORD
SCHEMBL11969108 0.75 KDM4E (0.47) IGF1RKDM4EHTTLMNAMAPT
SCHEMBL11968898 0.72 DRD2 (0.57) KDM4ELMNAMAPTSORDDRD2
SCHEMBL21733085 0.72 GAA (0.53) IGF1RKDM4EHTTLMNAMAPT
SCHEMBL4476580 0.72 KDM4E (0.69) IGF1RKDM4EHTTSMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120214798-A1 Novel Ethanediamone Hepcidine Antagonists VIFOR (INTERNATIONAL) AG (CH) 2012-08-23 US disclosed
EP-2475643-A1 NOVEL ETHANE DIAMINE HEPCIDIN ANTAGONISTS VIFOR (INTERNATIONAL) AG (CH) 2012-07-18 EP disclosed
WO-2011026959-A1 NOVEL ETHANE DIAMINE HEPCIDIN ANTAGONISTS VIFOR (INTERNATIONAL) AG (CH) 2011-03-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120214798-A1 Novel Ethanediamone Hepcidine Antagonists HAMP, SLC40A1, FTH1 IGF1R 2196/4885KDM4E 1676/4885HTT 2331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.